Clinical trials
Phase 2 Crohn Disease trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2021 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 6 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 3 |
| Bristol-Myers Squibb | 2 |
| Alfasigma S.p.A. | 1 |
| AstraZeneca | 1 |
| Biocad | 1 |
| EA Pharma Co., Ltd. | 1 |
| Eli Lilly and Company | 1 |
| Genentech, Inc. | 1 |
| Genzyme, a Sanofi Company | 1 |
| Lakefront Biotherapeutics NV | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Crohn Disease | 16 |
| Inflammatory Bowel Diseases | 5 |
| Colitis, Ulcerative | 2 |
| Gastroenteritis | 1 |
| Inflammation | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.